Literature DB >> 12908842

Defining monetary values for quality of life improvements: an exploratory study.

Jean Lachaine1, Claudine Laurier, André-Pierre Contandriopoulos.   

Abstract

BACKGROUND: QOL improvements, which can in many cases reflect the overall effect of a health intervention, are frequently measured. It would therefore be useful to define the monetary value of QOL improvements in order to subsequently estimate the value of a given intervention on the basis of its impact on QOL.
OBJECTIVE: To explore the feasibility of assessing the monetary value of an intervention by translating the improvement in QOL it produces into willingness to pay (WTP) amounts.
METHOD: Seven different hypothetical health state descriptions were developed. Five hundred and forty-five subjects randomly selected among the staff of the University of Montreal, Canada were sent a self-administered questionnaire asking them to evaluate the QOL corresponding to various hypothetical health states and indicate the amount they would be willing to pay for interventions that would enable them to move from these health states to perfect health.
RESULTS: The response rate was 55% (n = 294). A significant correlation was found between the WTP amount and the anticipated QOL improvement, and between the WTP amount and the respondent's family income. A regression equation for WTP amounts was derived from a step-wise model including the anticipated QOL improvement and the respondent income. While the model could only account for about 20% of the WTP variance (R(2) = 0.2), the mean predicted WTP amounts were very close to the mean WTP amounts observed in the sample.
CONCLUSION: This study indicates that a definite correlation exists between willingness to pay for an intervention and the improvement in QOL it produces.

Entities:  

Mesh:

Year:  2003        PMID: 12908842     DOI: 10.2165/00019053-200321120-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  12 in total

1.  Economic evaluation of drug therapy: a review of the contingent valuation method.

Authors:  M Johannesson; P O Johansson; B Jönsson
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 2.  Economic evaluation in health care: is there a role for cost-benefit analysis?

Authors:  M Johannesson; B Jönsson
Journal:  Health Policy       Date:  1991-02       Impact factor: 2.980

Review 3.  Health care contingent valuation studies: a review and classification of the literature.

Authors:  A Diener; B O'Brien; A Gafni
Journal:  Health Econ       Date:  1998-06       Impact factor: 3.046

4.  Risk reduction from low osmolality contrast media. What do patients think it is worth?

Authors:  L J Appel; E P Steinberg; N R Powe; G F Anderson; S A Dwyer; R R Faden
Journal:  Med Care       Date:  1990-04       Impact factor: 2.983

5.  Valuation of health changes with the contingent valuation method: a test of scope and question order effects.

Authors:  B Kartman; N O Stålhammar; M Johannesson
Journal:  Health Econ       Date:  1996 Nov-Dec       Impact factor: 3.046

6.  Using willingness to pay to assess the benefits of assisted reproductive techniques.

Authors:  M Ryan
Journal:  Health Econ       Date:  1996 Nov-Dec       Impact factor: 3.046

7.  Measuring heart patients' willingness to pay for changes in angina symptoms.

Authors:  L G Chestnut; L R Keller; W E Lambert; R D Rowe
Journal:  Med Decis Making       Date:  1996 Jan-Mar       Impact factor: 2.583

8.  The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.

Authors:  P J Neumann; M Johannesson
Journal:  Med Care       Date:  1994-07       Impact factor: 2.983

9.  What do patients value? Willingness to pay for ultrasound in normal pregnancy.

Authors:  D M Berwick; M C Weinstein
Journal:  Med Care       Date:  1985-07       Impact factor: 2.983

10.  A comparative study of seven measures of patient satisfaction.

Authors:  C K Ross; C A Steward; J M Sinacore
Journal:  Med Care       Date:  1995-04       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.